Home > Healthcare > Pharmaceuticals > Finished Drug Form > Female Sexual Dysfunction Treatment Market

Female Sexual Dysfunction Treatment Market Share

Report ID: GMI9138
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Female Sexual Dysfunction Treatment Market Share

The female sexual dysfunction treatment industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Female Sexual Dysfunction Treatment Market Companies

Some of the eminent market participants operating in the female sexual dysfunction treatment industry include:

Apricus Biosciences, Inc.
Cipla Limited
Freya Pharma Solutions
GSK plc
Lawley Pharmaceuticals Pty Ltd.
Merck & Co., Inc.
Millicent Pharma Limited
Novo Nordisk
Pfizer, Inc.
Sprout Pharmaceuticals, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Female sexual dysfunction treatment market size was USD 495.3 million in 2023 and is expected to register 10% CAGR from 2024-2032 owing to the increasing advancements in medical technology in the field of female sexual dysfunction (FSD) treatment worldwide.

The estrogen therapy segment is expected to reach USD 797.2 million by 2032 due to its capability to help alleviate vaginal dryness, itching, and discomfort which are common symptoms of FSD.

The U.S. female sexual dysfunction treatment industry is expected to register 9.7% CAGR from 2024-2032 due to well-developed healthcare infrastructure with modern facilities, advanced medical technology, and highly trained healthcare professionals in the region.

Cipla Limited, Freya Pharma Solutions, GSK plc, Lawley Pharmaceuticals Pty Ltd., Merck & Co., Inc., Millicent Pharma Limited, Novo Nordisk, Pfizer, Inc., and Sprout Pharmaceuticals, Inc., are some of the major female sexual dysfunction treatment companies worldwide.